Because hemolytic properties are responsible for the hemolysis that may take place during the use of a medical device.
It is the rupturing of red blood cells accompanied by the release of hemoglobin. Hemolysis can cause adverse effects in the patients’ health.
Thrombi are composed by a combination of red blood cells, platelets, fibrin and other cellular elements in blood. They can obstruct blood flow in the places where they are formed, preventing oxygen supply and blood flow to surrounding tissue. This can cause damage, destruction (infarction) and even the death or necrosis of tissue in that area.
The Hemolysis Test is an evaluation of hemocompatibility, designed to determine the hemolytic properties of finished medical devices and its components.
At BioAplicada we carry out for our clients the In Vitro Hemolysis Test for medical devices or materials that come into direct or indirect contact with blood.
The test is performed following the guidelines of ISO 10993-4 regulation.